FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33446511000001102: Wakix 18mg tablets (Bioprojet UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Oct 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
92621000001117 Wakix 18mg tablets (Bioprojet UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
92641000001110 Wakix 18mg tablets (Bioprojet UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Wakix 18mg tablets (Bioprojet UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has specific active ingredient Pitolisant hydrochloride true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Is a Pitolisant 18mg tablets true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has specific active ingredient Pitolisant hydrochloride false Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pitolisant false Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Is a Wakix true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Wakix 18mg tablets (Bioprojet UK Ltd) Has basis of strength substance Pitolisant true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Wakix 18mg tablets (Bioprojet UK Ltd) 30 tablet Has AMP True Wakix 18mg tablets (Bioprojet UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start